Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

133.50
Delayed Data
As of Jun 23
 -2.03 / -1.50%
Today’s Change
71.46
Today|||52-Week Range
137.26
+81.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash569.3M633.7M793.7M1.2B
 
 
 
 
 
Short Term Investment Cash79.9M56.0M89.5M438.0M
 
 
 
 
 
Cash & Short Term Investments1.5B1.4B1.1B1.5B
 
 
 
 
 
 
ReceivablesReceivables85.5M90.1M189.3M204.3M
 
 
 
 
 
 
InventoriesInventories14.1M30.8M57.2M77.6M
 
 
 
 
 
 
Current AssetsPrepaid Expenses--17.6M22.1M36.1M
 
 
 
 
Other Current Assets23.8M10.5M12.1M16.8M
 
 
 
 
 
Current Assets1.6B1.5B1.4B1.8B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.0B994.2M1.0B1.1B
 
 
 
 
 
Depreciation-308.3M-278.4M-336.1M-387.8M
 
 
 
 
 
Intangible Assets31.0M68.9M334.7M334.7M
 
 
 
 
 
Other Assets33.4M72.2M341.9M346.6M
 
 
 
 
 
Total Assets2.3B2.3B2.5B2.9B
 
 
 
 
 
 
LiabilitiesAccounts Payable49.3M71.2M74.9M61.5M
 
 
 
 
 
Short Term Debt16.9M32.0M87.0M319.4M
 
 
 
 
 
Accrued Expenses89.8M136.1M190.2M220.6M
 
 
 
 
 
Other Current Liabilities244.2M173.9M256.5M318.4M
 
 
 
 
 
Other Liabilities397.8M368.3M506.3M792.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt489.7M792.9M739.5M521.3M
 
 
 
 
 
Deferred Taxes0.00-15.0M-110.4M-134.1M
 
 
 
 
Other Liabilities11.6M34.5M39.2M102.1M
 
 
 
 
 
Total Liabilities962.6M1.2B1.4B1.6B
 
 
 
 
 
 
EquityMinority Interest-242.5M-4.2M-31.8M-28.0M
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity1.4B1.1B940.0M1.2B
 
 
 
 
 
Total Shareholder Equity1.4B1.1B940.0M1.2B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding233.8M241.8M246.3M248.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.